RB 5_22   Pharmaceuticalization of Obesity: Empirical Analysis of Metro and Nonmetro Populations, Cognitions and Behavior

This research uses microdata from the Kaiser Family Foundation’s Health Tracking Poll, 2023, to explore residents’ perceptions, attitude, and behavioral intentions toward new prescription weight loss drugs. Results of data analysis indicate that a majority of the current users of prescription weight loss drugs are from the metro, 84%. A typical new category user of prescription weight loss drugs is a White male, age 65 and above, with a college education.